Telomir Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function and returns cellular metals like Iron, copper, and zinc to homeostasis. Telomir 1 is a small molecule being developed as the regulator of telomere length and genomic stability.
Telomir Pharmaceuticals has raised $1.0M across 1 funding round on record, the most recent an undisclosed round of $1.0M announced in Apr 2026.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Telomir Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Telomir Pharmaceuticals Funding Rounds
Telomir Pharmaceuticals Founders and Leadership Team
Contact details for the Telomir Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Telomir Pharmaceuticals Funding Compared to Other Biotechnology Startups
Telomir Pharmaceuticals' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Telomir Pharmaceuticals in Biotechnology and Baltimore
Companies Similar to Telomir Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Telomir Pharmaceuticals Funding FAQs
What does Telomir Pharmaceuticals do?
Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function and returns cellular metals like Iron, copper, and zinc to homeostasis. Telomir 1 is a small molecule being developed as the regulator of telomere length and genomic stability.
How much funding has Telomir Pharmaceuticals raised?
Telomir Pharmaceuticals has raised $1.0M across 1 round on record. The most recent is an undisclosed round of $1.0M announced in Apr 2026.
When did Telomir Pharmaceuticals last raise funding?
Telomir Pharmaceuticals' most recent funding round on record is an undisclosed round of $1.0M, announced in Apr 2026.
Who founded Telomir Pharmaceuticals?
FundedIQ lists Erez Aminov (Founder) at Telomir Pharmaceuticals.
Where is Telomir Pharmaceuticals headquartered?
Telomir Pharmaceuticals is based in Baltimore, Maryland, United States.
How many employees does Telomir Pharmaceuticals have?
Telomir Pharmaceuticals is in the 1-10 employee band.
How does Telomir Pharmaceuticals' funding compare to other Biotechnology startups?
Telomir Pharmaceuticals' latest round of $1.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Telomir Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Telomir Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.